| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,280 |
8,644 |
$1.34M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,026 |
3,675 |
$768K |
| S9083 |
Global fee urgent care centers |
4,079 |
3,781 |
$499K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,028 |
8,345 |
$403K |
| 99215 |
Prolong outpt/office vis |
2,215 |
2,121 |
$354K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,952 |
8,548 |
$167K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
719 |
686 |
$105K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,276 |
6,010 |
$88K |
| 71046 |
Radiologic examination, chest; 2 views |
971 |
939 |
$66K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,070 |
987 |
$63K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
268 |
254 |
$49K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
800 |
771 |
$41K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
268 |
258 |
$41K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
499 |
474 |
$39K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
740 |
710 |
$25K |
| 99205 |
Prolong outpt/office vis |
92 |
92 |
$19K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
79 |
76 |
$18K |
| 94664 |
|
558 |
490 |
$7K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
343 |
329 |
$6K |
| 81001 |
|
802 |
772 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
138 |
130 |
$3K |
| 73140 |
|
41 |
41 |
$3K |
| 73610 |
|
18 |
18 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
698 |
654 |
$704.58 |
| 87807 |
|
112 |
106 |
$500.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
752 |
725 |
$66.93 |
| 87581 |
|
340 |
331 |
$0.00 |
| 87486 |
|
339 |
330 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.00 |
| 87186 |
|
12 |
12 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28 |
28 |
$0.00 |